Neurocrine Biosciences
NBIX
#1571
Rank
S$16.99 B
Marketcap
S$169.31
Share price
2.35%
Change (1 day)
13.91%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Earnings for Neurocrine Biosciences (NBIX)

Earnings in 2025 (TTM): S$0.81 Billion

According to Neurocrine Biosciences 's latest financial reports the company's current earnings are S$2.86 Billion. , an increase over its 2024 earnings that were of S$0.78 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Neurocrine Biosciences from 1996 to 2025

Annual earnings

Year Earnings Change
2025 S$0.81 B3.9%
2024 S$0.78 B96.41%
2023 S$0.40 B41.13%
2022 S$0.28 B73.74%
2021 S$0.16 B-8.82%
2020 S$0.17 B77.78%
2019 S$0.10 B49.83%
2018 S$67.3 M-142.57%
2017 -S$0.16 Billion-14.73%
2016 -S$0.19 Billion53.15%
2015 -S$0.13 Billion46.25%
2014 -S$82.79 Million29.66%
2013 -S$63.85 Million-3530.8%
2012 S$1.86 M-95.73%
2011 S$43.59 M
2009 -S$61.29 Million-45.38%
2008 -S$0.12 Billion-58.87%
2007 -S$0.28 Billion87.3%
2006 -S$0.15 Billion351.97%
2005 -S$32.23 Million-52.09%
2004 -S$67.27 Million-10.98%
2003 -S$75.56 Million
2001 -S$56.4 Million
1999 -S$25.44 Million108.32%
1998 -S$12.21 Million
1996 S$3.72 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
S$13.09 B 1,501.26%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
S$8.47 B 936.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$33.07 B 3,942.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
S$0.10 B-86.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-S$53.68 Million-106.56%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
S$64.96 M-92.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-S$6.17 Million-100.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Royalty Pharma
RPRX
S$2.09 B 156.38%๐Ÿ‡ฌ๐Ÿ‡ง UK